Related Experiment Video
Updated: Nov 13, 2025

08:33
Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
Published on: March 24, 2019
7.7K
Neurodegeneration and epigenetics: A review
1Department of Biotechnology, School of Life Sciences, Pondicherry University, Kalapet, Puducherry 605014, India.
Neurologia
|March 13, 2021
Summary
Epigenetic alterations in neuronal cells impact neurodegenerative diseases like Alzheimer's and Parkinson's. Future treatments must focus on targeted, non-cytotoxic epigenetic drugs for effective neuroprotection.
Area of Science:
- Neuroscience
- Epigenetics
- Genomics
Background:
- Neuronal function is regulated by genome and epigenome, with environmental factors influencing epigenetic changes.
- Dysregulation of both genome and epigenome leads to neurodegeneration.
- Epigenetic modifications are implicated in memory and various neurodegenerative disorders.
Purpose of the Study:
- To investigate diverse epigenome alterations in neuronal cells across different neurodegenerative disorder models.
- To understand the impact of epigenetic modifications on neurodegenerative diseases and memory.
- To explore therapeutic strategies targeting epigenetic dysregulation.
Main Methods:
- Analysis of epigenome alterations in neuronal cells from model organisms.
- Examination of epigenetic modifications including chromatin modification, DNA methylation, and regulatory RNAs (miRNA).
- Review of current therapeutic approaches and their limitations.
Main Results:
- Observed various epigenome alterations in neuronal cells linked to neurodegenerative disorders.
- Identified significant impact of epigenetic modifications on Alzheimer's, Parkinson's, and Huntington's diseases.
- Noted unique neuroepigenetic patterns in Prion Disease.
Conclusions:
- Epigenetic modifications are crucial in neurodegenerative disorders and memory function.
- Current epigenetic drugs targeting histone deacetylases and DNA methyltransferases have limitations in targeted delivery and cytotoxicity.
- Future therapeutic development should prioritize targeted, non-cytotoxic epigenetic drugs for neurodegenerative diseases.
Keywords:
DNA methylationEnfermedades neurodegenerativasEpigeneticsEpigenéticaHistone modificationMetilación de ADNModificación de histonasNeurodegenerative disordersMore Related Videos
Related Concept Videos
Neural Regulation
41.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
41.3K
Neurogenesis and Regeneration of Nervous Tissue
1.3K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.3K
Parkinson's Disease: Overview
1.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K
Alzheimer's Disease: Overview
1.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.0K
Epigenetic Regulation
3.4K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.4K
Epigenetic Regulation
32.0K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
32.0K

